(Q51837355)

13 April 2018

title

High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension. (English)

1 reference

13 April 2018

main subject

risk factor

0 references

cognitive dysfunction

1 reference

3

1 reference

13 April 2018

Toshio Matsumoto

9

object named as

Toshio Matsumoto

1 reference

13 April 2018

author name string

Shusuke Yagi

1

1 reference

13 April 2018

Masashi Akaike

2

1 reference

13 April 2018

Takashi Iwase

4

1 reference

13 April 2018

Sumiko Yoshida

5

1 reference

13 April 2018

Yuka Sumitomo-Ueda

6

1 reference

13 April 2018

Yasumasa Ikeda

7

1 reference

13 April 2018

Kazue Ishikawa

8

1 reference

13 April 2018

Masataka Sata

10

1 reference

13 April 2018

publication date

23 September 2010

1 reference

13 April 2018

published in

Hypertension Research

1 reference

13 April 2018

volume

34

1 reference

13 April 2018

issue

1

1 reference

13 April 2018

page(s)

74-78

1 reference

13 April 2018

The age-dependent relation of blood pressure to cognitive function and dementia

cites work

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Cognitive dysfunction and physical disability are associated with mortality in extremely elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Myocardial fibrosis and pathologic hypertrophy in the rat with renovascular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Aldosterone as a mediator in cardiovascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Effect of aldosterone and MR blockade on the brain and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Pathophysiological effects of aldosterone in cardiovascular tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

The brain mineralocorticoid receptor: greedy for ligand, mysterious in function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Heparin cofactor II is a novel protective factor against carotid atherosclerosis in elderly individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Relationship between cerebral blood flow and later cognitive decline in hypertensive patients with cerebral small vessel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Cerebral complications of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Effects of angiotensin II receptor blockers on dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Renin-angiotensin system in the brain as a new target of antihypertensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

The angiotensin II type 2 receptor in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Antihypertensive medication use and incident Alzheimer disease: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

MRI evidence of bilateral hippocampal sclerosis in amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Angiotensin converting enzyme inhibition partially prevents deficits in water maze performance, hippocampal synaptic plasticity and cerebral blood flow in streptozotocin-diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: relationship with spatial learning in young and aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

7 January 2021

Preferred technique for blood flow volume measurement in cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

7 January 2021

Aegis against stroke and dementia by angiotensin type 1 receptor blockers: new beneficial aspects

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

7 January 2021

Localization of aldosterone and corticosterone in the central nervous system, assessed by quantitative autoradiography

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

7 January 2021

Glucocorticoid receptor, mineralocorticoid receptors, 11β-hydroxysteroid dehydrogenase-1 and -2 expression in rat brain and kidney: in situ studies

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

7 January 2021

Vascular aldosterone in genetically hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.179

7 January 2021

Identifiers

DOI

10.1038/HR.2010.179

1 reference

13 April 2018

Dimensions Publication ID

1006865805

0 references

1 reference

13 April 2018